Citations 5

Interaction of cardiomyocytes from CCND2-overexpressing human induced pluripotent stem cells with electrically conductive hydrogels

RSC Advances | June 24, 2025 | Volume: 15 | Issue: 27 | Pages: 21408-21423

10.1039/d5ra03024b | PMID 40556703

Biomaterials like gold nanorod-embedded gelatin methacrylate (GelMA-GNR) hydrogels support the delivery of regenerative cells such as human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), enhancing EHT performance.
Insulin mitigates acute ischemia–induced atrial fibrillation and sinoatrial node dysfunction ex vivo

JCI Insight | November 14, 2024 | Volume: 10 | Issue: 1 | Pages: No page available

10.1172/jci.insight.185961 | PMID 39541171

Acute atrial ischemia is a well-known cause of postoperative atrial fibrillation (POAF). However, mechanisms through which ischemia contributes to the development of POAF are not well understood. In this study, ex vivo Langendorff perfusion was used to induce acute ischemia/reperfusion in the heart to mimic POAF. Inducibility of atrial fibrillation (AF) was evaluated using programmed electrical stimulation and verified with open-atrium optical mapping. Compared with the control group without ischemia, 25 minutes of ischemia substantially increased the incidence of AF. The right atrium was more susceptible to AF than the left atrium. Administering insulin for 30 minutes before ischemia and during reperfusion with 25 minutes of ischemia greatly reduced the vulnerability to AF. However, insulin treatment during reperfusion only did not show substantial benefits against AF. Optical mapping studies showed that insulin mitigated ischemia-induced abnormal electrophysiology, including shortened action potential duration and effective refractory period, slowed conduction velocity, increased conduction heterogeneity, and altered calcium transients. In conclusion, insulin reduced the risk of acute ischemia/reperfusion–induced AF via improving the electrophysiology and calcium handling of atrial cardiomyocytes, which provides a potential therapy for POAF.
Engineered Gold and Silica Nanoparticle-Incorporated Hydrogel Scaffolds for Human Stem Cell-Derived Cardiac Tissue Engineering

ACS Biomaterials Science & Engineering | February 7, 2024 | Volume: 10 | Issue: 4 | Pages: 2351-2366

10.1021/acsbiomaterials.3c01256 | PMID 38323834

Development and Characterization of Isogenic Cardiac Organoids from Human-Induced Pluripotent Stem Cells Under Supplement Starvation Regimen

ACS Biomaterials Science & Engineering | December 30, 2022 | Volume: 9 | Issue: 2 | Pages: 944-958

10.1021/acsbiomaterials.2c01290 | PMID 36583992

Three-dimensional scaffold-free microtissues engineered for cardiac repair

Journal of Materials Chemistry B | July 21, 2020 | Volume: 8 | Issue: 34 | Pages: 7571-7590

10.1039/d0tb01528h | PMID 32724973

In this review article, we present the state-of-the-art approaches and recent advancements in the engineering of scaffold-free cardiac microtissues for myocardial repair.